Study guide
10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
Key Takeaways Explain This Topic AI
Lynch syndrome is autosomal dominant DNA mismatch repair deficiency (MLH1, MSH2, MSH6, PMS2) with right-sided colonic and endometrial cancer predominance.
Familial adenomatous polyposis results from APC mutation, causes hundreds of adenomas and progresses to colorectal cancer without prophylactic colectomy.
Ischaemic colitis characteristically affects the splenic flexure and descending colon, the watershed territory between superior and inferior mesenteric artery supply.
Last updated: September 2026
- 4. Lower GI Disorders & Colonic Neoplasia
- Diverticular Disease
Colonic diverticula are acquired pseudodiverticula (mucosa and submucosa herniating through defects in the circular muscular layer where the nutrient vasa recta penetrate). Most prevalent in the sigmoid colon (~95%) in Western societies.
Diverticular Bleeding: Caused by eccentric arterial intimal thinning and rupture of the stretched vasa recta over the diverticular dome. Represents the single most common cause of acute, massive, painless lower GI haemorrhage in older adults. Resolves spontaneously in ~80% of cases.
Acute Diverticulitis: Micro- or macroscopic perforation of a diverticulum initiated by inspissated faecaliths. Manifests with left iliac fossa pain, pyrexia, altered bowel habit, and elevated CRP/WCC. Contrast-enhanced CT of the abdomen and pelvis is the diagnostic gold standard. Colonoscopy is strictly contraindicated in the acute phase due to high perforation risk.
Hinchey Classification of Acute Diverticulitis:
Stage I: Pericolic or mesenteric abscess / phlegmon.
Stage II: Pelvic, retroperitoneal, or distant intra-abdominal abscess.
Stage III: Generalized purulent peritonitis (ruptured abscess).
Stage IV: Generalized feculent peritonitis (free perforation with faecal contamination).
Management: Stages I–II with small abscesses (<3–4 cm) respond to intravenous antibiotics; larger abscesses require CT-guided percutaneous drainage. Stages III–IV mandate emergency resuscitation and surgical intervention, classically via a Hartmann's procedure (sigmoid colectomy, end colostomy in the left iliac fossa, and closure of the distal rectal stump) or primary resection with anastomosis and diverting loop ileostomy.
Colorectal Cancer Screening & Hereditary Syndromes
Colorectal cancer (CRC) is the fourth most common cancer in the UK. Population screening relies on the Faecal Immunochemical Test (FIT) , which uses specific antibodies against human globin to detect occult faecal bleeding at low concentrations without dietary restrictions. Approximately 5% of colorectal cancers are driven by well-characterized monogenic germline mutations:
Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer - HNPCC)
Genetic Architecture: Autosomal dominant inheritance caused by germline mutations in DNA mismatch repair (MMR) genes : MLH1 (~40%), MSH2 (~35%), MSH6 (~15%), and PMS2 (~5%), or epigenetic hypermethylation of the MLH1 promoter. Defective MMR machinery leads to replication slippage and the accumulation of mutations in repetitive nucleotide sequences, termed microsatellite instability (MSI-H) .
Clinical Characteristics: Accounts for ~3% of all CRCs. Tumours develop at a young age (mean age ~45 years), exhibit a marked predilection for the proximal / right colon (caecum and ascending colon in ~70%), and display distinct histological features: poorly differentiated, mucinous, signet-ring morphology, with dense lymphocytic infiltration (tumour-infiltrating lymphocytes).
Amsterdam II Criteria (The 3-2-1 Rule):
- At least 3 relatives with a Lynch-associated cancer (one of whom is a first-degree relative of the other two);
- At least 2 successive generations affected;
- At least 1 cancer diagnosed before age 50 ;
Familial adenomatous polyposis (FAP) excluded; tumours verified by pathology.
Extracolonic Malignancies:
Endometrial Adenocarcinoma: The most prevalent extracolonic cancer in women with Lynch syndrome (lifetime risk 40–60%, frequently presenting before the colorectal cancer).
Ovarian, gastric, small bowel (duodenum/jejunum), transitional cell carcinoma of the renal pelvis and ureter, hepatobiliary, and cutaneous sebaceous adenomas / keratoacanthomas ( Muir-Torre variant ); glioblastoma multiforme ( Turcot syndrome type 1 ).
Surveillance & Prevention: Total colonoscopy every 2 years starting at age 20–25 (or 5 years earlier than the youngest affected family member). Prophylactic daily aspirin reduces long-term colorectal cancer incidence by ~50% (CAPP2 trial). Prophylactic total hysterectomy and bilateral salpingo-oophorectomy should be considered once childbearing is complete.
Familial Adenomatous Polyposis (FAP)
Genetic Architecture: Autosomal dominant disorder caused by germline inactivating mutations in the APC (Adenomatous Polyposis Coli) tumour suppressor gene on chromosome 5q21. The APC protein forms a destruction complex that degrades cytosolic beta-catenin; loss of APC causes constitutive activation of the Wnt/beta-catenin signalling pathway, driving cellular hyperproliferation.
Clinical Characteristics: Characterized by the development of hundreds to thousands of colorectal adenomatous polyps carpeting the entire colon and rectum, typically emerging in puberty (second decade). If left untreated, progression to colorectal adenocarcinoma occurs in 100% of patients by age 40–50 .
Extracolonic Features:
Duodenal and Ampullary Adenomas: Occur in >90% of FAP patients; the second leading cause of cancer death in FAP. Requires lifelong surveillance using forward- and side-viewing duodenoscopy graded via Spigelman staging .
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE): Present at birth in >80% of patients. Asymptomatic, pigmented, bilateral oval fundoscopic lesions that serve as an invaluable clinical phenotypic marker in at-risk children.
Gardner Syndrome Phenotype: FAP plus prominent extra-abdominal manifestations: desmoid tumours (locally invasive, non-metastasizing fibroblastic mesenteric tumours; high surgical morbidity), osteomas (particularly of the mandible and skull), epidermoid cysts, and dental abnormalities (impacted or supernumerary teeth).
Turcot Syndrome Type 2: FAP associated with central nervous system medulloblastoma .
Management: Annual flexible sigmoidoscopy/colonoscopy starting at age 12–14 . Definitive management mandates prophylactic restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) or total colectomy with ileorectal anastomosis (IRA), typically performed in late adolescence before malignant transformation ensues.
Diverticular Disease, Ischaemic Colitis and Angiodysplasia
Three non-neoplastic colonic conditions account for most lower gastrointestinal bleeding in older UK patients, and they are separated by pain, pattern of bleeding and vascular risk.
Condition Typical presentation Key discriminator
Diverticular bleeding Painless, brisk, self-limiting fresh red bleeding Commonest cause of major lower GI bleeding; stops spontaneously in about 80%
Acute diverticulitis Left iliac fossa pain, fever, raised inflammatory markers Bleeding is unusual during acute diverticulitis
Ischaemic colitis Sudden left-sided abdominal pain then bloody diarrhoea Splenic flexure/descending colon watershed; thumbprinting on imaging
Angiodysplasia Recurrent occult or overt bleeding, iron deficiency Associated with aortic stenosis (Heyde syndrome) and chronic kidney disease
Heyde syndrome links calcific aortic stenosis to angiodysplastic bleeding through acquired type 2A von Willebrand factor deficiency, caused by shear-induced cleavage of high-molecular-weight multimers across the stenotic valve; valve replacement corrects the coagulopathy.
Colorectal Cancer: Presentation and UK Screening
Right-sided tumours present late with iron deficiency anaemia and weight loss because the caecal lumen is wide and the stool liquid; left-sided tumours present earlier with change in bowel habit and obstruction . Unexplained iron deficiency anaemia in any man, or in any woman after the menopause, requires investigation of both upper and lower gastrointestinal tracts.
The NHS bowel cancer screening programme uses the faecal immunochemical test (FIT) , which detects human globin and therefore does not require dietary restriction, offered to eligible adults every two years, with colonoscopy for those above the threshold. FIT is also used in symptomatic primary care patients to prioritise referral.
Hereditary Syndromes Beyond Lynch and FAP
Peutz-Jeghers syndrome : autosomal dominant STK11 mutation, mucocutaneous pigmentation of lips and buccal mucosa, hamartomatous polyps causing intussusception, raised risk of gastrointestinal, breast and pancreatic cancer.
MUTYH-associated polyposis : autosomal recessive , phenotypically similar to attenuated FAP — the pedigree without vertical transmission is the clue.
Juvenile polyposis syndrome : SMAD4 or BMPR1A , with SMAD4 cases overlapping hereditary haemorrhagic telangiectasia.